Abstract:Coronavirus disease-2019 (COVID-19), caused by SARS-CoV-2, has rapidly spread to most of countries in the world, threatening the health and lives of many people. Unfortunately, information regarding the immunological characteristics in COVID-19 patients remains limited. Here we collected the blood samples from 18 healthy donors (HD) and 38 COVID-19 patients to analyze changes in the adaptive immune cell populations and phenotypes. In comparison to HD, the lymphocyte percentage was slightly decreased, the percentages of CD4 and CD8 T cells in lymphocytes are similar, whereas B cell percentage increased in COVID-19 patients. T cells, especially CD8 T cells, showed an enhanced expression of late activation marker CD25 and exhaustion marker PD-1. Importantly, SARS-CoV-2 induced an increased percentage of T follicular helpher (Tfh)- and germinal center B-like (GCB-like) cells in the blood. However, the parameters in COVD-19 patients remained unchanged across various age groups. Therefore, we demonstrated that the T and B cells can be activated normally and exhibit functional features. These data provide a clue that the adaptive immunity in most people could be primed to induce a significant immune response against SARS-CoV-2 infection upon receiving standard medical care. ### Competing Interest Statement The authors have declared no competing interest. ### Clinical Trial COVID-19 infection was excluded from clinical trial registrition. ### Funding Statement This work was supported by grants from Natural Science Foundation of China (No. 81820108017), Natural Science Foundation of China (No. 81771673), and COVID-19 special project of Xi'an Jiaotong University Foundation (xzy032020002). We thank all the doctors, nurses, public health workers, and patients for their contribution against SARS-CoV-2 infection. ### Author Declarations All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript. Yes All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable. Yes All the data are available in the manuscript.

Distinct immune signatures discriminate between asymptomatic and presymptomatic SARS-CoV-2 pos subjects

Distinct immune signatures discriminate between asymptomatic and presymptomatic SARS-CoV-2pos subjects

Single-cell immune profiling reveals distinct immune response in asymptomatic COVID-19 patients

Proteomics Investigation of Diverse Serological Patterns in COVID-19

Overly Exuberant Innate Immune Response to SARS-CoV-2 Infection

Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections

Analysis of adaptive immune cell populations and phenotypes in the patients infected by SARS CoV 2

Identification of Distinct Immune Cell Subsets Associated With Asymptomatic Infection, Disease Severity, and Viral Persistence in COVID-19 Patients

Antibody dynamics to SARS‐CoV‐2 in asymptomatic COVID‐19 infections

Silent battles: immune responses in asymptomatic SARS-CoV-2 infection

Distinct lipid metabolic dysregulation in asymptomatic COVID-19

Viral dynamics and antibody responses in people with asymptomatic SARS-CoV-2 infection

Impaired T Cell Functions along with Elevated Activated Tregs at the Early Stage of Asymptomatic SARS-CoV-2 Infection

Clinical characteristics of asymptomatic carriers of novel coronavirus disease 2019: A multi-center study in Jiangsu Province

Comparative Characterization and Risk Stratification of Asymptomatic and Presymptomatic Patients With COVID-19

Longitudinal Characteristics of T Cell Responses in Asymptomatic SARS-CoV-2 Infection

Identification of Distinct Immune Cells Associated with Various Clinical Presentations of COVID-19

Transcriptome Analysis of Peripheral Blood Mononuclear Cells Reveals Distinct Immune Response in Asymptomatic and Re-Detectable Positive COVID-19 Patients

Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection

Identification of TCR Repertoires in Asymptomatic COVID-19 Patients by Single-Cell T-cell Receptor Sequencing

Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study